Bio Impact Capital LLC Compass Therapeutics, Inc. Transaction History
Bio Impact Capital LLC
- $669 Million
- Q4 2024
A detailed history of Bio Impact Capital LLC transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Bio Impact Capital LLC holds 8,567,896 shares of CMPX stock, worth $25.4 Million. This represents 1.86% of its overall portfolio holdings.
Number of Shares
8,567,896
Previous 5,641,894
51.86%
Holding current value
$25.4 Million
Previous $10.4 Million
19.67%
% of portfolio
1.86%
Previous 1.62%
Shares
4 transactions
Others Institutions Holding CMPX
# of Institutions
89Shares Held
93.2MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA22.4MShares$66.4 Million0.88% of portfolio
-
Blackstone Inc New York, NY10MShares$29.8 Million0.07% of portfolio
-
Black Rock Inc. New York, NY6.61MShares$19.6 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.99MShares$17.8 Million0.02% of portfolio
-
Tang Capital Management LLC San Diego, CA5.9MShares$17.5 Million0.64% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $301M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...